- Home
- PHGE
as 05-30-2025 4:00pm EST
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
| Founded: | 2015 | Country: | Israel |
| Employees: | N/A | City: | NESS ZIONA |
| Market Cap: | 14.6M | IPO Year: | N/A |
| Target Price: | $20.00 | AVG Volume (30 days): | 85.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $4.90 | Next Earning Date: | 05-15-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BiomX Inc. COmmon Stock News
PHGE Breaking Stock News: Dive into PHGE Ticker-Specific Updates for Smart Investing
GOBankingRates
9 hours ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
9 hours ago
Will Tesla have to play catch up to Waymo's robotaxis?
Yahoo Finance
9 hours ago
Why Scott Bessent wants to make it easier for banks to own Treasurys
The Guardian
9 hours ago
When are people too old to do their jobs?
GlobeNewswire
9 hours ago
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
GlobeNewswire
9 hours ago
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PR Newswire
9 hours ago
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
CNW Group
9 hours ago
Statement by Minister Guilbeault on Portuguese Heritage Month
Compare PHGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHGE BiomX Inc. COmmon Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.